CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Capex Y/Y Annual
Kyverna Therapeutics Inc   (NASDAQ: KYTX)
Other Ticker:  
 
 

KYTX's Capital Expenditures Growth by Quarter and Year

Kyverna Therapeutics Inc 's Capital Expenditures results by quarter and year

 



KYTX Capital Expenditures (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December - 0.53 0.00 0.00
3rd Quarter September - 0.10 0.00 0.00
2nd Quarter June - 1.03 0.00 0.00
1st Quarter March 0.00 0.54 0.00 0.00
FY   0.00 2.20 0.00 0.00





KYTX Capital Expenditures first quarter 2025 Y/Y Growth Comment
Kyverna Therapeutics Inc in the first quarter 2025 recorded Capital Expenditures of $ 0.00 millions.

According to the results reported in the first quarter 2025, Kyverna Therapeutics Inc achieved the best Capital Expenditures growth in Biotechnology & Pharmaceuticals industry. While Kyverna Therapeutics Inc ' s Capital Expenditures no change of % ranks overall at the positon no. in the first quarter 2025.


KYTX Capital Expenditures ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Kyverna Therapeutics Inc 's first quarter 2025 Capital Expenditures $ 0.00 millions KYTX's Income Statement
Kyverna Therapeutics Inc 's first quarter 2024 Capital Expenditures $ 0.54 millions Quarterly KYTX's Income Statement


KYTX Capital Expenditures (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - 430 % - -
3rd Quarter September - -90.29 % - -
2nd Quarter June - 90.74 % - -
1st Quarter March - - - -
FY (Year on Year)   - - - -


Suppliers by KYTX Divisions >> Back to KYTX Growth rate Comparisons >>


Capital Expenditures first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Capital Expenditures first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Capital Expenditures by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Kyverna Therapeutics Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KYTX's I. Quarter Q/Q Capital Expenditures Comment
I. Quarter 2025 Capital Expenditures of 0.00 millions by Kyverna Therapeutics Inc come out even more unfavourable compare to the Capital Expenditures 0.53 millions in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Kyverna Therapeutics Inc achieved highest sequential Capital Expenditures growth. While Kyverna Therapeutics Inc 's Capital Expenditures growth quarter on quarter, overall rank is .


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KYTX's I. Quarter Q/Q Capital Expenditures Comment
Recent accomplishment of 0.00 millions by Kyverna Therapeutics Inc appear even worse if you take a look at 0.53 millions a quarter before.

Within Biotechnology & Pharmaceuticals industry Kyverna Therapeutics Inc achieved highest sequential Capital Expenditures growth. While Kyverna Therapeutics Inc 's Capital Expenditures growth quarter on quarter, overall rank is .


Kyverna Therapeutics Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 2.21 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #


Cumulative Capital Expenditures growth Comment
In the Mar 31 2025 period, Kyverna Therapeutics Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Kyverna Therapeutics Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Mar 31 2025 period, Kyverna Therapeutics Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Kyverna Therapeutics Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Biotechnology & Pharmaceuticals Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
KYTX's Capital Expenditures Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for KYTX's Competitors
Capital Expenditures Growth for Kyverna Therapeutics Inc 's Suppliers
Capital Expenditures Growth for KYTX's Customers

You may also want to know
KYTX's Annual Growth Rates KYTX's Profitability Ratios KYTX's Asset Turnover Ratio KYTX's Dividend Growth
KYTX's Roe KYTX's Valuation Ratios KYTX's Financial Strength Ratios KYTX's Dividend Payout Ratio
KYTX's Roa KYTX's Inventory Turnover Ratio KYTX's Growth Rates KYTX's Dividend Comparisons



Companies with similar Capital Expenditures no change for the quarter ending Mar 31 2025 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2025
Select Medical Holdings Corp-0.34%$ -0.339 millions
Si bone inc -0.48%$ -0.480 millions
Vaxart Inc -0.76%$ -0.763 millions
Mettler Toledo International Inc-0.78%$ -0.782 millions
Idexx Laboratories Inc-0.82%$ -0.816 millions
Gilead Sciences Inc -0.95%$ -0.952 millions
Johnson and Johnson-1.49%$ -1.487 millions
Iqvia Holdings Inc -2.07%$ -2.069 millions
Cadre Holdings inc -2.53%$ -2.532 millions
Myriad Genetics Inc -3.49%$ -3.488 millions
Irhythm Technologies Inc -3.65%$ -3.652 millions
Becton Dickinson And Company-3.73%$ -3.731 millions
Msa Safety Inc-3.88%$ -3.877 millions
Neurocrine Biosciences Inc -4.46%$ -4.464 millions
Vaxcyte Inc -4.47%$ -4.473 millions
Harvard Bioscience Inc -5.14%$ -5.139 millions
Procept Biorobotics Corporation-5.65%$ -5.653 millions
Labcorp Holdings Inc -5.83%$ -5.830 millions
Crinetics Pharmaceuticals Inc -6.98%$ -6.982 millions
Maravai Lifesciences Holdings Inc -7.59%$ -7.590 millions
Amneal Pharmaceuticals Inc -8.13%$ -8.128 millions
Bristol myers Squibb Company-8.45%$ -8.451 millions
Community Health Systems Inc -8.60%$ -8.602 millions
Organon and Co -9.38%$ -9.375 millions
Treace Medical Concepts Inc -9.78%$ -9.778 millions
Novocure Limited-9.95%$ -9.954 millions
Revvity Inc-10.43%$ -10.435 millions
Icu Medical Inc-10.68%$ -10.684 millions
Carlisle Companies Incorporated-10.77%$ -10.769 millions
Teladoc Health Inc -11.06%$ -11.058 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com